Alzheimer's
Alnylam, Biogen show gene-silencing data for Alzheimer’s therapies
Anika Sharma
This week, Alnylam and Biogen took a significant step toward redefining the landscape of Alzheimer’s disease treatment by revealing promising ...
FDA Advisory Committee Vote Validates LEQEMBI Alzheimer’s Treatment
SG Tylor
Source: Eisai On June 9, 2023, the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) of the US Food ...
Eisai has requested to approve Leqembi, its therapy for Alzheimer’s disease, in South Korea
SG Tylor
This filing comes just before an FDA advisory committee meeting, which has raised expectations of the drug receiving full approval ...
